Best Estimates of Asthma Control in Children

  • Megan E. Partridge
  • William K. Dolen
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Asthma is a disease caused by the chronic inflammation with resulting airway hyper-responsiveness and reversible obstruction. Although the underlying pathophysiology of the condition is similar in adults and children, differences exist between these two populations because the pediatric lung is not just a smaller version of the adult lung. Because of a narrower airway, children may have asthma symptoms when exposed to stimuli that an adult may tolerate without symptoms. Since the pediatric lung is still developing, chronic inflammation may result not only in current asthma symptoms, but also in a permanent decrease in lung function [1]. On the global level, asthma prevalence is increasing at a disproportionate rate in children, compared to adults. Asthma has become the most common chronic disease of childhood, affecting approximately 9 million children less than 18 years of age [2].


Asthma Severity Asthma Control Allergy Clin Immunol Asthma Symptom Peak Expiratory Flow Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rietveld S, Creer TL (2003) Psychiatric factors in asthma: implications for diagnosis and therapy. Am J Respir Med 2(1):1–10PubMedGoogle Scholar
  2. 2.
    Bloom, B. and A.N. Dey, Summary health statistics for U.S. children: National Health Interview Survey, 2004. Vital Health Stat 10, 2006. (227): p. 1–85Google Scholar
  3. 3.
    Vollmer, W.M., Assessment of asthma control and severity. Ann Allergy Asthma Immunol, 2004. 93 (5): p. 409–13; quiz 414–6, 492PubMedCrossRefGoogle Scholar
  4. 4.
    Cockcroft DW, Swystun VA (1996) Asthma control versus asthma severity. J Allergy Clin Immunol 98(6 Pt 1):1016–8CrossRefPubMedGoogle Scholar
  5. 5.
    Humbert M et al (2007) Asthma control or severity: that is the question. Allergy 62(2):95–101CrossRefPubMedGoogle Scholar
  6. 6.
    Gustafsson PM et al (2006) Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. Int J Clin Pract 60(3):321–34CrossRefPubMedGoogle Scholar
  7. 7.
    Li J et al (2005) Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol 116 (5): p. S3–11CrossRefGoogle Scholar
  8. 8.
    Schatz M et al (2006) Determinants of future long-term asthma control. J Allergy Clin Immunol 118(5):1048–53CrossRefPubMedGoogle Scholar
  9. 9.
    Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol, 1991. 88 (3 Pt 2): p. 425–534Google Scholar
  10. 10.
    Von Mutius, E., Presentation of new GINA guidelines for paediatrics. The Global Initiative on Asthma. Clin Exp Allergy, 2000. 30 (Suppl 1): p. 6–10CrossRefGoogle Scholar
  11. 11.
    Bousquet J et al (2007) GINA guidelines on asthma and beyond. Allergy 62(2):102–12CrossRefPubMedGoogle Scholar
  12. 12.
    Covar RA et al (2004) Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170(3):234–41CrossRefPubMedGoogle Scholar
  13. 13.
    Sears MR et al (2003) A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349(15):1414–22CrossRefPubMedGoogle Scholar
  14. 14.
    Morgan WJ et al (2005) Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 172(10):1253–8CrossRefPubMedGoogle Scholar
  15. 15.
    Kikuchi Y et al (1994) Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 330(19):1329–34CrossRefPubMedGoogle Scholar
  16. 16.
    Kendrick AH et al (1993) Accuracy of perception of severity of asthma: patients treated in general practice. BMJ 307(6901):422–4CrossRefPubMedGoogle Scholar
  17. 17.
    Baker RR et al (2000) Poor perception of airway obstruction in children with asthma. J Asthma 37(7):613–24CrossRefPubMedGoogle Scholar
  18. 18.
    Shingo S, Zhang J, Reiss TF (2001) Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J 17(2):220–4CrossRefPubMedGoogle Scholar
  19. 19.
    Luskin AT (2005) What the asthma end points we know and love do and do not tell us. J Allergy Clin Immunol 115(4 Suppl):S539–45CrossRefPubMedGoogle Scholar
  20. 20.
    Schatz M et al (2005) Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 115(5):1049–55CrossRefPubMedGoogle Scholar
  21. 21.
    Newacheck PW, Halfon N (2000) Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med 154(3):287–93PubMedGoogle Scholar
  22. 22.
    Cohen P et al (1998) Prospective associations between somatic illness and mental illness from childhood to adulthood. Am J Epidemiol 147(3):232–9PubMedGoogle Scholar
  23. 23.
    DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–7CrossRefPubMedGoogle Scholar
  24. 24.
    Kullowatz A et al (2007) Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 101(3):638–44CrossRefPubMedGoogle Scholar
  25. 25.
    Gandhi RK, Blaiss MS (2006) What are the best estimates of pediatric asthma control? Curr Opin Allergy Clin Immunol 6(2):106–12CrossRefPubMedGoogle Scholar
  26. 26.
    Juniper EF et al (1992) Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47(2):76–83CrossRefPubMedGoogle Scholar
  27. 27.
    Juniper EF et al (1996) Measuring quality of life in children with asthma. Qual Life Res 5(1):35–46CrossRefPubMedGoogle Scholar
  28. 28.
    Liu A et al (2007) Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 119(4):817–825CrossRefPubMedGoogle Scholar
  29. 29.
    Gendo K, Lodewick MJ (2005) Asthma economics: focusing on therapies that improve costly outcomes. Curr Opin Pulm Med 11(1):43–50CrossRefPubMedGoogle Scholar
  30. 30.
    Lozano P et al (1999) The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 104(5):957–63CrossRefPubMedGoogle Scholar
  31. 31.
    Malone DC, Lawson KA, Smith DH (2000) Asthma: an analysis of high-cost patients. Pharm Pract Manag Q 20(1):12–20PubMedGoogle Scholar
  32. 32.
    Stempel DA et al (2005) Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol 115(5):935–9CrossRefPubMedGoogle Scholar
  33. 33.
    Alvarez GG et al (2005) A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 12(5):265–70PubMedGoogle Scholar
  34. 34.
    Naureckas ET et al (2005) Short-acting beta-agonist prescription fills as a marker for asthma morbidity. Chest 128(2):602–8CrossRefPubMedGoogle Scholar
  35. 35.
    Kanengiser S, Dozor AJ (1994) Forced expiratory maneuvers in children aged 3 to 5 years. Pediatr Pulmonol 18(3):144–9CrossRefPubMedGoogle Scholar
  36. 36.
    Kamps AW, Brand PL (2001) Education, self-management and home peak flow monitoring in childhood asthma. Paediatr Respir Rev 2(2):165–9CrossRefPubMedGoogle Scholar
  37. 37.
    Kamps AW, Roorda RJ, Brand PL (2001) Peak flow diaries in childhood asthma are unreliable. Thorax 56(3):180–2CrossRefPubMedGoogle Scholar
  38. 38.
    Gibson PG (2000) Monitoring the patient with asthma: an evidence-based approach. J Allergy Clin Immunol 106(1 Pt 1):17–26CrossRefPubMedGoogle Scholar
  39. 39.
    Kotses H, Harver A, Humphries CT (2006) Home monitoring in asthma self-management. J Asthma 43(9):649–55CrossRefPubMedGoogle Scholar
  40. 40.
    Brand PL, Roorda RJ (2003) Usefulness of monitoring lung function in asthma. Arch Dis Child 88(11):1021–5CrossRefPubMedGoogle Scholar
  41. 41.
    Fuhlbrigge AL et al (2001) FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 107(1):61–7CrossRefPubMedGoogle Scholar
  42. 42.
    Liu AH (2005) Biomarkers and childhood asthma: improving control today and tomorrow. Allergy Asthma Proc 26(4):249–54PubMedGoogle Scholar
  43. 43.
    Horak E et al (2003) Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ 326(7386):422–3CrossRefPubMedGoogle Scholar
  44. 44.
    Paull K et al (2005) Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999–2002. Pediatr Pulmonol 39(4):311–7CrossRefPubMedGoogle Scholar
  45. 45.
    Olaguibel JM et al (2005) Comparative analysis of the bronchodilator response measured by impulse oscillometry (IOS), spirometry and body plethysmography in asthmatic children. J Investig Allergol Clin Immunol 15(2):102–6PubMedGoogle Scholar
  46. 46.
    Papadopouli E et al (2006) Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma. Respir Med 100(8):1442–50CrossRefPubMedGoogle Scholar
  47. 47.
    Riedler J, Robertson CF (1994) Effect of tidal volume on the output and particle size distribution of hypertonic saline from an ultrasonic nebulizer. Eur Respir J 7(5):998–1002PubMedGoogle Scholar
  48. 48.
    Cai Y et al (1998) Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J 11(4):848–53CrossRefPubMedGoogle Scholar
  49. 49.
    Gibson PG et al (2003) Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 58(2):116–21CrossRefPubMedGoogle Scholar
  50. 50.
    Green RH et al (2002) Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360(9347):1715–21CrossRefPubMedGoogle Scholar
  51. 51.
    Covar RA et al (2004) Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol 114(3):575–82CrossRefPubMedGoogle Scholar
  52. 52.
    Li AM et al (2005) Induced sputum in childhood asthma. Hong Kong Med J 11(4):289–94PubMedGoogle Scholar
  53. 53.
    Taylor DR (2006) Nitric oxide as a clinical guide for asthma management. J Allergy Clin Immunol 117(2):259–62CrossRefPubMedGoogle Scholar
  54. 54.
    Smith AD et al (2005) Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352(21):2163–73CrossRefPubMedGoogle Scholar
  55. 55.
    Delgado-Corcoran C et al (2004) Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 5(1):48–52CrossRefPubMedGoogle Scholar
  56. 56.
    Jones SL et al (2001) The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 164(5):738–43PubMedGoogle Scholar
  57. 57.
    Jones SL et al (2002) Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 20(3):601–8CrossRefPubMedGoogle Scholar
  58. 58.
    Bateman ED, Bousquet J, Braunstein GL (2001) Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 17(4):589–95CrossRefPubMedGoogle Scholar
  59. 59.
    Bateman, E.D., et al., Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study [see comment]. Am J Respir Crit Care Med, 2004. 170 (8): p. 836–44CrossRefPubMedGoogle Scholar
  60. 60.
    Lemanske RF Jr (2002) Genetics and the variability of treatment response in asthma. J Allergy Clin Immunol 109(6 Suppl):S521–4CrossRefPubMedGoogle Scholar
  61. 61.
    Israel E (2005) Genetics and the variability of treatment response in asthma. J Allergy Clin Immunol 115(4 Suppl):S532–8CrossRefPubMedGoogle Scholar
  62. 62.
    Murphy KR (2005) Asthma: versatile treatment for a variable disease. J Asthma 42(3):149–57PubMedGoogle Scholar
  63. 63.
    Rabe KF et al (2004) Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114(1):40–7CrossRefPubMedGoogle Scholar
  64. 64.
    Canonica GW et al (2007) Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy 62(6):668–74CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Megan E. Partridge
    • 1
  • William K. Dolen
    • 1
  1. 1.Allergy-Immunology Section, Departments of Pediatrics and MedicineMedical College of GeorgiaAugustaUSA

Personalised recommendations